DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$8.72
Tradestie Score
46
Market Cap
$354.59M
Analyst Upside
+77.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.13
|
$505.12M | 2.9 | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.38
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$9.18
|
$468.01M | - | 48 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.84
|
$463.20M | - | 47 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$5.92
|
$457.09M | - | 53 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.32
|
$454.29M | - | 56 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$11.85
|
$448.32M | - | 50 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
More DMAC Analysis
Data updated: Oct 26, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry